US Patent Issued to Dexcom on April 7 for "Bayesian framework for personalized model identification and prediction of future blood glucose in type 1 diabetes using easily accessible patient data" (Italian Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,040, issued on April 7, was assigned to Dexcom Inc. (San Diego).

"Bayesian framework for personalized model identification and prediction of future blood glucose in type 1 diabetes using easily accessible patient data" was invented by Giacomo Cappon (Padua, Italy), Andrea Facchinetti (Trissino, Italy), Giovanni Sparacino (Padua, Italy) and Simone Del Favero (Valle di Cadore, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of predicting future blood glucose concentrations of an individual patient includes: selecting an individualized nonlinear physiological model of glucose-insulin dynamics, the selected model having a plurality of mode...